DOAJ
Open Access
2022
P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL
P. L. Zinzani
M. Özcan
K. Sapunarova
W. Jurczak
A. Hamed
+16 lainnya
Topik & Kata Kunci
Penulis (21)
P
P. L. Zinzani
M
M. Özcan
K
K. Sapunarova
W
W. Jurczak
A
A. Hamed
K
K. Bouabdallah
G
G. Saydam
K
K. Geissler
Á
Á. Szomor
M
M. Lazaroiu
A
A. Salar
A
A. Tempescul
M
M. Nalcaci
L
L. Gercheva
M
M. Egyed
P
P. Panayiotidis
L
L. Mongay Soler
A
A. Cao
C
C. Phelps
B
B. H Childs
M
M. J Matasar
Format Sitasi
Zinzani, P.L., Özcan, M., Sapunarova, K., Jurczak, W., Hamed, A., Bouabdallah, K. et al. (2022). P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL. https://doi.org/10.1097/01.HS9.0000847420.24995.43
Akses Cepat
PDF tidak tersedia langsung
Cek di sumber asli →Informasi Jurnal
- Tahun Terbit
- 2022
- Sumber Database
- DOAJ
- DOI
- 10.1097/01.HS9.0000847420.24995.43
- Akses
- Open Access ✓